Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours

Por Checkley, D, Tessier, J J, Kendrew, J, Waterton, J C, Wedge, S R
Publicado em 2003

Overcoming the Low Relaxivity of Gadofosveset at High Field with Spin Locking

Por Richardson, O C, Scott, M L J, Tanner, S F, Waterton, J C, Buckley, D L
Publicado em 2012

31P-magnetic resonance spectroscopy and 2H-magnetic resonance imaging studies of a panel of early-generation transplanted murine tumour models.

Por Robinson, S. P., van den Boogaart, A., Maxwell, R. J., Griffiths, J. R., Hamilton, E., Waterton, J. C.
Publicado em 1998

Measurement and visualisation of focal cartilage thickness change by MRI in a study of knee osteoarthritis using a novel image analysis tool

Por Williams, T G, Holmes, A P, Bowes, M, Vincent, G, Hutchinson, C E, Waterton, J C, Maciewicz, R A, Taylor, C J
Publicado em 2010

Tumour biomechanical response to the vascular disrupting agent ZD6126 in vivo assessed by magnetic resonance elastography

Por Li, J, Jamin, Y, Boult, J K R, Cummings, C, Waterton, J C, Ulloa, J, Sinkus, R, Bamber, J C, Robinson, S P
Publicado em 2014

False-negative MRI biomarkers of tumour response to targeted cancer therapeutics

Por Boult, J K R, Jamin, Y, Jacobs, V, Gilmour, L D, Walker-Samuel, S, Halliday, J, Elvin, P, Ryan, A J, Waterton, J C, Robinson, S P
Publicado em 2012

Can cartilage loss be detected in knee osteoarthritis (OA) patients with 3–6 months' observation using advanced image analysis of 3 T MRI?

Por Hunter, D.J., Bowes, M.A., Eaton, C.B., Holmes, A.P., Mann, H., Kwoh, C.K., Maciewicz, R.A., Samuels, J., Waterton, J.C.
Publicado no Osteoarthritis Cartilage (2010)

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI

Por Beloueche-Babari, M, Jamin, Y, Arunan, V, Walker-Samuel, S, Revill, M, Smith, P D, Halliday, J, Waterton, J C, Barjat, H, Workman, P, Leach, M O, Robinson, S P
Publicado em 2013

Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging

Por Robinson, S P, McIntyre, D J O, Checkley, D, Tessier, J J, Howe, F A, Griffiths, J R, Ashton, S E, Ryan, A J, Blakey, D C, Waterton, J C
Publicado em 2003

Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation

Por Skeoch, S., Cristinacce, P. L. Hubbard, Williams, H., Pemberton, P., Xu, D., Sun, J., James, J., Yuan, C., Hatsukami, T., Hockings, P. D., Alexander, M. Y., Waterton, J. C., Bruce, I. N.
Publicado no Sci Rep (2017)

Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives

Por deSouza, N. M., Winfield, J. M., Waterton, J. C., Weller, A., Papoutsaki, M.-V., Doran, S. J., Collins, D. J., Fournier, L., Sullivan, D., Chenevert, T., Jackson, A., Boss, M., Trattnig, S., Liu, Y.
Publicado no Eur Radiol (2017)

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations

Por Leach, M O, Brindle, K M, Evelhoch, J L, Griffiths, J R, Horsman, M R, Jackson, A, Jayson, G C, Judson, I R, Knopp, M V, Maxwell, R J, McIntyre, D, Padhani, A R, Price, P, Rathbone, R, Rustin, G J, Tofts, P S, Tozer, G M, Vennart, W, Waterton, J C, Williams, S R, Workman, P
Publicado em 2005